Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17090836 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2917826 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2920003 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL10984369 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL17090784 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2922266 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2921079 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2918415 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2920815 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL2917797 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724507-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| US-20240424147-A1 | PHTHALOCYANINE-LOADED MICELLES FOR THE DIRECT VISUALIZATION OF TUMORS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-12-26 | — | — | US | claimed |
| WO-2024253829-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | claimed |
| WO-2023060147-A1 | PHTHALOCYANINE-LOADED MICELLES FOR THE DIRECT VISUALIZATION OF TUMORS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-04-13 | — | — | WO | claimed |
| EP-0279501-B1 | NOVEL NAPHTHALOCYANINE DYE,METHOD FOR PREPARING THE SAME, AND OPTICAL INFORMATION RECORDING MEDIUM EMPLOYING THE SAME | Hitachi Chemical Co., Ltd. (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0375967-A1 | Naphthalocyanine compounds and process for their preparation | Hitachi Chemical Co., Ltd. (JP) | 1990-07-04 | — | — | EP | claimed |
| US-4927735-A | READING STABILITY | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1990-05-22 | — | — | US | claimed |
| US-4900817-A | Multiring phthalocyanine compounds | EDISON POLYMER INNOVATION CORPORATION (US) | 1990-02-13 | — | — | US | claimed |
| EP-0279501-A1 | Novel naphthalocyanine dye,method for preparing the same, and optical information recording medium employing the same | Hitachi Chemical Co., Ltd. (JP) | 1988-08-24 | — | — | EP | claimed |
| EP-0243205-A1 | Electrophotographic plate | Hitachi Chemical Co., Ltd. (JP) | 1987-10-28 | — | — | EP | claimed |
| JP-63055556-A | — | — | None | — | — | JP | disclosed |
| US-20250313752-A1 | METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4527841-A1 | METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-03-26 | — | — | EP | disclosed |
| US-12247044-B2 | Composition, photoelectric conversion element, and imaging device | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-03-11 | — | — | US | disclosed |
| CN-119367521-A | Multifunctional self-bionic nano vaccine for treating breast cancer and preparation method and application thereof | 广州医科大学附属第二医院 | 2025-01-28 | — | — | CN | disclosed |
| US-4725525-A | Recording information media comprising chromophores | HOEBBST CELANESE CORPORATION (US) | 1988-02-16 | — | — | US | disclosed |
| EP-0254553-A2 | Optical recording medium | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1988-01-27 | — | — | EP | disclosed |
| EP-0243205-A1 | Electrophotographic plate | Hitachi Chemical Co., Ltd. (JP) | 1987-10-28 | — | — | EP | disclosed |
| EP-0191970-A1 | Recording information media comprising chromophores | CELANESE CORPORATION (US) | 1986-08-27 | — | — | EP | disclosed |
| US-3972982-A | EXTRACTION WITH A SILANE AND A HYDROCARBYL AMINE | MONSANTO COMPANY (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247044-B2 | Composition, photoelectric conversion element, and imaging device | TRRAP, NR2E3, INTS9 | TSHR 1811/4885THRB 3107/4885LMNA 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.